osimertinib
astrazeneca
['adaura', 'osimertinib']
so only 79 of 343 patients (23%) in placebo arm got subsequent osimertinib in #adaura. would love to see os results subgrouped by those who got subsequent osi versus those who did not. #asco23 
Personal account. Med Onc. Associate Prof. @queensoncology @QueensuPHS. #cancerpolicy #cancergroundshot. Pubs: https://t.co/FTRPKNykq3 Talks- https://t.co/anav3AIZjO